Macquarie Group’s Neurogene NGNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-697
| Closed | -$35 | – | 2052 |
|
|
2024
Q1 | $35 | Buy |
+697
| New | +$35 | ﹤0.01% | 1662 |
|
|
2021
Q4 | – | Sell |
-11,960
| Closed | -$86K | – | 2630 |
|
|
2021
Q3 | $86K | Buy |
11,960
+11,442
| +2,209% | +$82.3K | ﹤0.01% | 2030 |
|
|
2021
Q2 | $5K | Hold |
518
| – | – | ﹤0.01% | 2528 |
|
|
2021
Q1 | $6K | Sell |
518
-246
| -32% | -$2.85K | ﹤0.01% | 2440 |
|
|
2020
Q4 | $11K | Hold |
764
| – | – | ﹤0.01% | 2296 |
|
|
2020
Q3 | $9K | Hold |
764
| – | – | ﹤0.01% | 2291 |
|
|
2020
Q2 | $13K | Sell |
764
-4,807
| -86% | -$81.8K | ﹤0.01% | 2252 |
|
|
2020
Q1 | $63K | Buy |
+5,571
| New | +$63K | ﹤0.01% | 1765 |
|
|
2018
Q1 | – | Sell |
-600
| Closed | -$7K | – | 2306 |
|
|
2017
Q4 | $7K | Buy |
+600
| New | +$7K | ﹤0.01% | 2333 |
|